Business Wire Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 12 Jun 2025 DARMSTADT, Germany Not intended for UK-, US- or Canada ...

CRISPR Therapeutics AG stock has soared 90% since May, driven by Casgevy approval and future breakthroughs in gene editing.

Updated European Alliance of Associations for Rheumatology Guidelines on Lupus Nephritis The updated EULAR recommendations on the management of lupus nephritis (LN) were also presented. 6 Kidney ...

A NATIONWIDE Swedish study, presented at the EULAR 2025 Congress, has revealed a strong association between social ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.